HIS
KZR

Harvest Investment Services’s Kezar Life Sciences KZR Stock Holding History

Harvest Investment Services’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,402
Closed -$198K – 134
2022
Q2 		$198K Buy
+2,402
New +$212K 0.15% 140

Other funds holding KZR

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Harvest Investment Services's KZR Position: Q3 2022 in Review

Harvest Investment Services sold out of Kezar Life Sciences (KZR) in Q3 2022, closing a stake of 2,402 shares — an estimated $198K sold.

Harvest Investment Services first reported a position in KZR in Q2 2022 and held it in 1 quarter. The position peaked at $198K in Q2 2022. 132 funds tracked by Wall St. Rank hold KZR as of Q3 2022.

  • Harvest Investment Services reported no remaining Kezar Life Sciences position as of Q3 2022 after selling out during the quarter.
  • Harvest Investment Services sold 2,402 Kezar Life Sciences shares in Q3 2022, an estimated $198K.
  • Harvest Investment Services first reported a position in Kezar Life Sciences in Q2 2022 and held it in 1 quarter.
  • Harvest Investment Services's Kezar Life Sciences position peaked at $198K in Q2 2022.
  • 132 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2022.

Based on Harvest Investment Services's 13F filing for Q3 2022, filed 9 Nov 2022.